Zacks Small Cap Research – SNGX: Presentation Highlights HyBryte Potential in CTCL… – Go Health Pro
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Presentation Highlights HyBryte Potential in CTCL In January 2025, Dr. Neal Bhatia presented at two dermatology conferences on “Off-Label Uses of PDT” (photodynamic therapy). Dr. Bhatia is the Director of Clinical Dermatology at Therapeutics Clinical Research, a member of Soligenix’s (NASDAQ:SNGX) scientific … Read more
